Skip to content

Clinical trials

Active, not recruiting Observational Leukemia, Myeloid, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Observational Status: Active, not recruiting Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20141
20193
20205
20232
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
City of Hope Medical Center2
Rigshospitalet, Denmark2
AbbVie1
Alliance for Clinical Trials in Oncology1
Assistance Publique - Hôpitaux de Paris1
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia1
Guangdong Second Provincial General Hospital1
H. Lee Moffitt Cancer Center and Research Institute1
IRCCS Azienda Ospedaliero-Universitaria di Bologna1
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute17
Myelodysplastic Syndromes4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Lymphoma, Non-Hodgkin3
Multiple Myeloma3
Congenital Abnormalities2
Hematologic Diseases2
Hematologic Neoplasms2
Hodgkin Disease2
Leukemia, Lymphocytic, Chronic, B-Cell2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.